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Abstract
Background: Endometriosis affects women’s physical and mental wellbeing. Symp-
toms include dyspareunia, dysmenorrhea, pelvic pain, and infertility. The purpose of 
this study is to assess the correlation between some relevant factors and symptoms 
and risk of an endometriosis diagnosis in infertile women.    
Materials and Methods: A retrospective study of 1282 surgical patients in an infertility 
Institute, Iran between 2011 and 2013 were evaluated by laparoscopy. Of these, there 
were 341 infertile women with endometriosis (cases) and 332 infertile women with a 
normal pelvis (comparison group). Chi-square and t tests were used to compare these two 
groups. Logistic regression was done to build a prediction model for an endometriosis 
diagnosis.
Results: Gravidity [odds ratio (OR): 0.8, confidence interval (CI): 0.6-0.9, P=0.01], par-
ity (OR: 0.7, CI: 0.6-0.9, P=0.01), family history of endometriosis (OR: 4.9, CI: 2.1-11.3, 
P<0.001), history of galactorrhea (OR: 2.3, CI: 1.5-3.5, P=0.01), history of pelvic surgery 
(OR: 1.9, CI: 1.3-2.7, P<0.001), and shorter menstrual cycle length (OR: 0.9, CI: 0.9-0.9, 
P=0.04) were associated with endometriosis. Duration of natural menstruation and age of 
menarche were not correlated with subsequent risk of endometriosis (P>0.05). Fatigue, 
diarrhea, constipation, dysmenorrhea, dyspareunia, pelvic pain and premenstrual spot-
ting were more significant among late-stage endometriosis patients than in those with 
early-stage endometriosis and more prevalent among patients with endometriosis than 
that of the comparison group. In the logistic regression model, gravidity, family history of 
endometriosis, history of galactorrhea, history of pelvic surgery, dysmenorrhoea, pelvic 
pain, dysparaunia, premenstrual spotting, fatigue, and diarrhea were significantly associ-
ated with endometriosis. However, the number of pregnancies was negatively related to 
endometriosis.
Conclusion: Endometriosis is a considerable public health issue because it affects many 
women and is associated with the significant morbidity. In this study, we built a prediction 
model which can be used to predict the risk of endometriosis in infertile women.   
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Introduction 
Endometriosis is the benign proliferation of 
functioning endometrial glands and stroma, lo-
cated outside of the uterine cavity. It is diagnosed 
by laparoscopic observation of lesions, nodules, 
or cysts on the pelvic peritoneum or the pelvic or-
gans (1), and is one of the most common diseases 
in gynecology field (2), as well as a source of an 
exorbitant economic burden in public health field 
(3). Endometriosis could be considered as an epi-
genetic, hormonal regulated disease (4, 5) which 
is progesterone resistance, and estrogens promote 
perilesional angiogenesis and neo-innervation and 
allow endometriotic foci to growth. Moreover, es-
trogens may contribute to decreases in the local 
immune surveillance by Peritoneal Fluid Mononu-
clear Cells (6, 7) and enhance the pro-inflammato-
ry microenvironment typical of the disease (8, 9). 
Endometriosis, as an enigmatic disease, is respon-
sible for chronic pelvic pain, dysmenorrhea, men-
orrhagia, dyspareunia and infertility (2, 10-12). 
The range of the variable influence on the result-
ing pain syndrome in endometriosis is very wide, 
for example, classified according to the revised 
American Society for Reproductive Medicine 
(rASRM) classification, previous surgical proce-
dures, Douglas obliteration, extent of the sub-peri-
toneal infiltration and pelvic wall implants (13). It 
has been observed that there is no relation between 
the intensity of the pain experienced and stages of 
disease. Regardless of disease stage, women with 
endometriosis seem to have similar menstrual pat-
terns and ages at menarche (12). Some studies 
have revealed an increased risk of other diseases 
among the women with endometriosis (14, 15). 
Approximately, one half of the infertile women 
facing surgery are diagnosed with endometriosis 
(16). Despite this relatively high prevalence and 
morbidity, little information has been published 
about the risk factors for endometriosis in infertile 
women, who are more likely to have endometrio-
sis as an underlying cause of their infertility.
The relationship between endometriosis in in-
fertile women and clinical symptoms is a com-
plex association, which is influenced by multiple 
factors including psychological, different cultural 
conditions, ethnic, and climatic conditions. There-
fore, the aim of this study is to determine the de-
mographic, personal characteristic, reproductive 
variables, contraception and menstruation pattern 
associated with the presence of endometriosis in 
infertile women. We also investigated the param-
eters that might predict the risk of an endometrio-
sis diagnosis.
 
Materials and Methods
In retrospective study, the subjects were 1282 
currently infertile [the failure to achieve a clini-
cal pregnancy after 1 year or more of regular un-
protected sexual intercourse (17) women aged 
16-46 years who underwent laparoscopy between 
2011 and 2013. The study was approved by the 
Institutional Review Board of the Royan Institute 
Research Center and the Royan Ethics Commit-
tee according to the Helsinki Declaration; signed 
informed written consent was obtained from all 
participants. The information was collected by 
using a self-administered questionnaire, which 
included questions about demographic character-
istics, family history, health of reproductive and 
infertility, symptoms and physical characteristics. 
Characteristics of the menstrual cycle included age 
at menarche, average length of menstrual bleed-
ing and cycle, previous use of oral contraceptives 
(OC, total number of years taken), previous usage 
of intrauterine device (IUD), age at first pregnancy 
and pelvic pain.
The most common indications for laparoscopy 
were as follows: symptoms of endometriosis, such 
as dyspareunia, dysmenorrhea and pelvic pain, 
unexplained factor in infertility, uterine abnormal-
ity and tubo-peritoneal disorder. After laparoscopy, 
we divided the 1282 participants into three groups, 
shown in the diagram. The first group of 341 pa-
tients had visual lesions of endometriosis (52 had 
stage I, 85 had stage II, 111 had stage III, and 84 
had stage IV); the second group of 609 patients had 
adhesions, fibroids, leiomyomas, and/or uterine ab-
normalities; the third group of 332 subjects had no 
visual lesions of endometriosis, i.e., a normal pelvis 
without any complications (Fig.1). In analysis, the 
second group was excluded in order to evaluate the 
risk factors in women with endometriosis (pure en-
dometriosis) compared with the group with a nor-
mal pelvis and no other complications.
All clinicians of the study were required to col-
lect the following information from all participants: 
history of infertility, gravidity, parity, ectopic preg-
nancies, abortion, pathologies of the reproductive 
tract (e.g., sexually transmitted diseases, pelvic in-
flammatory disease (PID), and salpingitis), any ob-
servations during surgery (e.g., uterine anomalies, 
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tubal obstruction, leiomyoma, and adhesions), and 
any medication taken on a regular basis. Weight 
and height of all female infertility referring to the 
Center are measured during the first visit. Body 
mass index (BMI) is defined as weight divided by 
height squared (kg/m2).
Symptoms of endometriosis (in last 6 months) 
were collected, such as dysmenorrhoea, pelvic 
pain, dyspareunia, premenstrual spotting, fatigue, 
diarrhea and constipation. Other symptoms in-
dicative of endometriosis are as follows: irregular 
bleeding, severe bleeding, bloat, nausea, vomiting, 
dyschezia and dysuria.
Following surgery, the stage of the disease was 
defined according to the rASRM as stage I (mini-
mal), stage II (mild), stage III (moderate), and 
stage IV (severe) (18). In 80.2% of women with 
endometriosis, histologic confirmation was also 
made. 
Statistical analysis was performed by using 
SPSS program (Version 18,  Chicago, IL, USA), 
comparing those with a diagnosis of endome-
triosis and those with a normal pelvis using Chi-
square or t tests, as appropriate. In order to predict 
a diagnosis of endometriosis, we used logistic 
regression. The data were expressed as means ± 
SD. Odds ratio (OR) and 95% confidence interval 
(95% CIs) were also calculated for each factor. In 
order to build a prediction model, we used step-
wise logistic regression in a backward manner. In 
this model, a P value of 0.15 was used as entry cri-
terion, whereas a P value of 0.1 was the threshold 
for a variable to stay in the model. The area under 
the receiver operating characteristic (ROC) curve 
(AUC) shows the discriminative performance of 
the fitted logistic model. An AUC equal to 0.5 
shows no discriminative performance, whereas 
an AUC of 1.0 indicates perfect discrimination. 
In ordinal regression analysis, predictors which 
probably reflect symptoms of endometriosis (such 
as dyspareunia, dysmenorrhea and pelvic pain) 
were examined. P values less than 0.05 were con-
sidered to be statistically significant. Moreover, 
we assessed the calibration of the model by com-
paring the predicted probability in a category of 
patients and the observed percentage of endome-
triosis in that category. According, we categorized 
the predicted probabilities in 10 groups, based on 
percentile points with steps of 10% per step. In 
each category, we compared the mean predicted 
probability in that particular category with the 
observed probability, i.e., the number of women 
with endometriosis in that category divided by the 
total number of women in that category. The re-
sults were plotted graphically.
Fig.1: Flow chart showing longitudinal analysis of the population.
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Results
The prevalence of endometriosis in the total 
sample of women undergoing laparoscopy was 
26.5%. The women’s demographic and reproduc-
tive characteristics are listed in Table 1. The study 
group (cases) consisted of 341 infertile women, 
who were diagnosed to have endometriosis by lap-
aroscopy. The severity of the disease was staged 
according to the rASRM classification of endo-
metriosis. Endometriosis was staged as 15.2% 
minimal (rASRM stage I), 24.9% mild (rASRM 
stage II), 32.5% moderate (rASRM stage III) and 
24.3% severe (rASRM stage IV). All these women 
were infertile [primary infertility in 296 (89.2% of 
women) and secondary infertility in 36 (10.8% of 
women)], with mean age of 32.4 ± 4.9 years, mean 
age at menarche of 13.1 ± 1.2 years, mean duration 
of infertility of 5.8 ± 1.6 years (Table 1).
As a comparison, the 332 infertile women 
who referred to the same center for infertil-
ity and were laparoscopically confirmed to be 
without endometriosis were included. All these 
women were infertile [primary infertility in 296 
(87.4%) of women and secondary infertility in 
34 (12.6%) of women], with mean age of 31.4 
± 5.2 years, mean age at menarche of 13.1 ± 1.3 
years and mean duration of infertility of 6.0 ± 
1.8 years (Table 1).
Independent t test analysis showed no signifi-
cant difference in BMI between the case and the 
comparison groups (P>0.05). Those with endo-
metriosis did not differ from the comparison 
group with regard to age at menarche, menstru-
al status, duration of menstrual bleeding, type 
of infertility, duration of infertility and cigarette 
smoking. In contrast, a significant difference 
was found concerning the length of menstrual 
cycles, age, gravidity and history of abortion 
(Table 1). 
We also found no association between endome-
triosis and the use of IUD or previous exposure 
to OCs. No significant difference was found be-
tween the two groups in previous cervical trauma, 
genital tract abnormality, history of  PID and sex-
ually transmitted diseases (STD) (i.e., chlamydia, 
herpes, condylomas, and gonorrhea).
Table 1: Selected demographic, personal, and lifestyle characteristics of the case and the comparison groups
Parameters Comparison group Cases OR (95% CI) P value
Age (Y)
<30 155 (45.5) 118 (35.5) 1†
30-35 103 (30.2) 126 (38) 1.6 (1.1- 2.2) 0.02
>35 83 (24.3) 88 (26.5) 1.3 (0.9- 2.04)
Age at menarche (Y) 13.1 ± 1.3 13.1 ± 1.2 0.9 (0.8-1.10) 0.7
Age at marriage (Y) 20.3 ± 3.8 22.1 ± 4.6 1.1 (0.9-1.2) 0.8
Night worker
No 338 (99.1) 325 (97.9) 1†
Yes 3 (0.9) 7 (2.1) 2.4 (0.6-9.4) 0.2
Menstruation status
Irregular 47 (86.2) 42 (12.7) 1† 0.6 
Regular 294 (13.8) 290 (87.3) 1.10 (0.7-1.7)
Menstrual cycle length 31.1 ± 7.8 29.9 ± 7.5 0.9 (0.9-0.9) 0.04
Duration of bleeding menstrual (days) 6.0 ± 1.8 5.8 ± 1.6 0.9 (0.8-1.05) 0.4
History of live birth
Yes 43 (12.6) 36 (10.8) 1†
No 298 (87.4) 296 (89.2) 1.1 (0.7-1.9) 0.4
Type of infertility
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Table 1: Continued
Parameters Comparison group Cases OR (95% CI) P value
Secondary 43 (12.6) 36 (10.8) 1† 0.4
Primary 298 (87.4) 296 (89.2) 1.1 (0.7-1.9)
Duration of infertility (Y) 6.90 ± 4.3 6.7 ± 4.5 0.9 (0.9-1.03) 0.8
Contraceptive
None 189 (55.4) 167 (50.3) 1†
OCP 26 (7.6) 27 (8.1) 1.1 (0.6-2.09) 0.2
IUD 8 (2.3) 3 (0.9) 0.4 (0.1-1.6)
Other 118 (34.6) 135 (40.7) 1.2 (0.9-1.7)
Duration of consume 
contraceptive (month)
30.9 ± 20.09 30.2 ± 20.1 0.9 (0.9-1.009) 0.7
Gravidity 0.5 ± 1.1 0.3 ± 0.8 0.8 (0.6-0.9) 0.01
Parity 0.4 ± 1.08 0.3 ± 0.6 0.7 (0.6-0.9) 0.01
BMI (kg/m2) 25.6 ± 3.8 25.05 ± 4.01 0.9 (0.9-1.002) 0.06
No. of spontaneous
abortion
Smoking
0.4 ± 1.06 0.2 ± 0.5 0.7 (0.5-0.8) 0.02
No 337 (98.8) 326 (98.2) 1†
Yes 4 (1.2) 6 (1.8) 1.5 (0.4-5.5) 0.5
Family history of endometriosis
No 334 (97.4) 301 (90.7) 1† <0.001
Yes 7 (2.1) 31 (9.3) 4.9 (2.1-11.3)
History of galactoreahea
No 302 (88.6) 255 (76.8) 1† <0.001
Yes 39 (11.4) 77 (23.2) 2.3 (1.5-3.5)
Abnormality genital tract
No 259 (76) 272 (81.9) 1† 0.05 
Yes 82 (24) 60 (18.1) 0.6 (0.4-1.01)
History of STD
No 340 (99.7) 331 (99.7) 1† 0.9
Yes 1 (0.3) 1 (0.3) 1.02 (0.06-16.4)
History of PID
No 337 (99.8) 325 (97.9) 1† 0.3 
Yes 4 (1.2) 7 (2.1) 1.8 (0.5-6.2)
History pelvic surgery
No. surgery 126 (37) 77 (23.2) 1†
Laparoscopy 180 (52.8) 189 (56.9) 1.7 (1.2-2.4)
Laparoscopy and laparotomy 11 (3.2) 42 (12.7) 1.6 (0.8-3.08) <0.001
Laparotomy 24 (7) 24 (7.2) 6.2 (3.03-12.8)
Previous cervical trauma
No. trauma 332 (97.7) 317 (95.5) 1† 0.1
Trauma 9 (2.6) 15 (4.5) 1.7 (0.7-4.04)
Data are presented as n (%) or mean ± SD.
†; Reference category, OR; Odds ratio, CI; Confidence interval, OCP; Oral contraceptives, IUD; Intrauterine device, BMI; Body mass index, 
STD; Sexually transmitted disease and PID; Pelvic inflammatory disease.
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However, patients with endometriosis were 
significantly more likely to have a family his-
tory of endometriosis, a history of galactorrhea, 
and a history of pelvic surgery (Table 1). 
Symptom distribution among patients with 
early-stage (stage I or II disease) and late-stage 
(stage III or IV disease) endometriosis is summa-
rized in Table 2, which shows that dysmenorrhea, 
dyspareunia, pelvic pain, premenstrual spotting, 
fatigue, diarrhea and constipation were more 
common among late-stage endometriosis patients 
than in those with early-stage endometriosis and 
more prevalent among patients with endometrio-
sis than those with a normal pelvis (Table 2).
Finally, in order to build a prediction model 
and to find the most important factors affecting 
endometriosis, we used a logistics regression 
model in a backward manner. Table 3 shows the 
result of fitting logistic regression model to the 
data.
In the logistic regression model, gravidity, 
family history of endometriosis, history of ga-
lactorrhea, history of pelvic surgery, dysmenor-
rhoea, pelvic pain, dysparaunia, premenstrual 
spotting, fatigue, and diarrhea were significant-
ly positively associated with endometriosis. 
However, number of pregnancies was negative-
ly related to endometriosis (Table 3). 
Table 2: Distribution of symptoms associated with endometriosis according to disease stage and comparison group
Parameters Disease stage Comparison
group
1st 2nd 3rd 4th
n (%)
P value OR (95% CI)
n (%) n (%) n (%) n (%)
Dysmenorrhoea
Yes 28 (53.8) 52 (61.2) 79 (71.2) 68 (81) 140 (41.1) 3.1 (2.2.-4.2)
No 24 (46.2) 33 (38.8) 32 (28.8) 16 (19) 201 (58.9) <0.001 1†
Dysparunia
Yes 15 (28.8) 32 (37.6) 39 (35.1) 46 (54.8) 68 (19.9) 2.6 (1.8-3.7)
No 37 (71.2) 53 (62.4) 72 (64.9) 38 (45.2) 273 (80.1) <0.001 1†
Pelvic Pain
Yes 16 (30.8) 56 (34.1) 52 (46.8) 44 (52.4) 65 (19.1) 3.1 (2.2-4.4)
No 36 (69.2) 29 (65.9) 59 (53.2) 40 (47.6) 276 (80.9) 0.02 1†
Premenstrual 
spotting
Yes 7 (13.5) 27 (31.8) 31 (27.9) 41 (48.8) 42 (12.3) 3.3 (2.2-4.6)
No 45 (86.5) 58 (68.2) 80 (72.1) 43 (51.2) 299 (87.7) <0.001 1†
Fatigue
Yes 3 (5.8) 12 (14.1) 12 (10.8) 20 (23.8) 16 (4.7) 3.3 (1.8-6.0)
No 49 (94.2) 73 (85.9) 99 (89.2) 64 (76.2) 325 (95.3) <0.001 1†
Diarrhea
Yes 2 (3.8) 6 (7.11) 8 (7.2) 9 (10.7) 1 (0.3) 27.6 (3.7-205.5)
No 50 (96.2) 79 (92.9) 103 (92.8) 75 (89.3) 340 (99.7) <0.001 1†
Constipation
Yes 3 (5.8) 16 (22.4) 13 (11.7) 16 (19) 32 (9.4) 1.7 (1.09-2.8)
No 49 (94.2) 66 (77.6) 98 (88.3) 68 (81) 309 (90.6) 0.003 1†
†; Reference category, OR; Odds ratio and CI; Confidence interval.
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The AUC shows the discriminative perfor-
mance of the logistic model. The AUC value 
equal to 0.5 shows no discriminative perfor-
mance, while AUC value of 1.0 indicates perfect 
discrimination. The AUC value for the fitted lo-
gistic model was 0.78 (95% CI 0.74-0.81), show-
ing a good predictive performance for the fitted 
logistic regression model (Fig.2). We checked 
the goodness of fit of our model by the Hosmer-
Lemeshow goodness of fit test. The P value  for 
this test was 0.13 showing good predictive per-
formance of our model. Also validity of the mod-
el was assessed by calibration plot; all predicted 
probabilities were almost similar to the observed 
rate of endometriosis in each group and show the 
good calibration of the model.
Table 3: Result of fitting multiple logistic regression
Parameters OR (95% CI) P value
Gravidity 0.8 (0.6-0.9) 0.04
Family history of endometriosis 2.7 (1.06-7.1) 0.03
History of galactoreahea 1.8 (1.1-3.05) 0.01
History of pelvic surgery
No. surgery 1†
Laparoscopy 3.4 (1.5-7.8) <0.001
Laparotomy 4.1 (2.4-6.8)
Laparoscopy and laparotomy 14.5 (6.1-34.2)
Dysmenorrhoea 1.8 (1.1-2.8) 0.006
Pelvic pain 4.1 (2.4-6.8) <0.001
Dysparunia 1.6 (1.09-2.4) 0.01
Premenstrual spotting 2.2 (1.3-3.6) 0.002
Fatigue 2.6 (1.3-5.1) 0.006
Diarrhea 19.06 (2.4-150.6) 0.005
Area under ROC curve (95% CI)=0.78 (0.74-0.81)
†; Reference category, OR; Odds ratio, CI; Confidence interval and ROC; Receiver operating characteristic.
Fig.2: Receiver operating characteristic (ROC) curve for assessment discriminative preformance of logistic regression.
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Discussion
Endometriosis is one of the most common gy-
necological diseases in the different countries. 
It is a confusing disease with little known about 
its distribution, true prevalence and risk factors 
in the population (19). In our study, prevalence 
of endometriosis in the total sample of women 
undergoing laparoscopy was 26.5%. Ozkan et 
al. (20) found endometriosis has a prevalence 
of 25-40% in infertile women. The goal of this 
study was to investigate the relation between 
some relevant factors and risk of an endometrio-
sis diagnosis. Our study represents an analysis 
of 673 infertile women undergoing laparoscopy 
(cases and comparison group) for further under-
standing of the different risk factors and associ-
ated symptoms of endometriosis with infertility.
A significant difference was observed be-
tween the average age of infertile women with 
and without endometriosis (32.4 ± 4.9 vs. 31.4 
± 5.2). Increasing age, alcohol use, low body 
weight, family history of endometriosis, early 
menarche, prolonged menstrual flow, and short 
cycle interval, intercourse during menses, in-
fertility are also alleged risk factors (21, 22). 
Our results show no significant difference as-
sociation between BMI or smoking intake and 
endometriosis. This is consistent with the sev-
eral studies showing no association with these 
parameters and endometriosis (22, 23). Some 
authors have reported inverse relation between 
BMI and endometriosis (24, 25), although in 
these latter studies the comparison group was 
not infertile women.
The present study indicated a higher rate of 
endometriosis among more educated women 
(data not shown), is consistent with the results 
of other studies (2, 26). The possible association 
of endometriosis with higher education level 
is due to a delay in childbearing. The associa-
tion between education level and endometriosis 
probably reflects the socioeconomic issues, such 
as access to the medical care. The absence of 
gravidity in endometriosis group was associated 
with significantly increased odds of suffering 
from endometriosis; a finding that is consistent 
with several other reports (26, 27). However, 
spontaneous abortions and ectopic pregnancy 
were not linked to endometriosis (14). In the 
present study, we did not find any significant 
difference between duration of infertility and 
endometriosis. Akande et al. (28) reported that 
the effects of duration of infertility and primary 
infertility were not observed to be statistically 
significant for women with endometriosis. Sev-
eral studies show that prolonged duration of 
infertility itself may be a precursor of endome-
triosis in the absence of other causes (29, 30). 
Duration and heaviness of flow and premenstru-
al spotting were also risk factors for endome-
triosis (P<0.05). The majority of studies to date 
have reported that early menarche (<11 years) 
increases the risk of endometriosis (23, 31, 32), 
but our result did not find any significant dif-
ference between age of menarche and endome-
triosis. Peterson et al. (33) reported that there 
was no relationship between endometriosis and 
menstrual cycle history, including average cycle 
length, number of menstrual cycles, and age at 
menarche.
Cramer et al. (32) found in their case-control 
study that women with infertility associated 
with endometriosis had a lower age at menarche, 
shorter menstrual cycles and longer duration of 
menstrual bleeding than those of the control 
group. Likewise, we found no significant differ-
ence between the heavy menstrual flow and the 
risk of endometriosis. Treloar et al. (34) have 
also reported the same result, even though heavy 
flow is associated with endometriosis in the oth-
er studies (1, 35). A recent study has reported 
that a shorter cycle length is associated with an 
increasing risk of endometriosis, but none of 
these studies has examined specifically this as-
sociation before the onset of symptoms (1, 36). 
Overall, these findings support the Sampson’s 
theory of retrograde menstruation, in which 
women with greater opportunity for menstrual 
contamination of the pelvis are at increased risk 
of endometriosis (34, 37).
We found significant correlation between 
length of cycle and the presence of endome-
triosis, but other studies reported no significant 
association between length of cycle, length of 
menses, as well as age at menarche with the 
presence of endometriosis (2, 34). Multiple 
lines of evidence have indicated that endome-
triosis is associated with increased exposure to 
menstruation, an assumption supporting the ret-
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rograde menstruation theory (1, 36). Menstrual 
factors, previously shown to be associated with 
endometriosis, include early menarche, shorter 
cycle length, longer menses, late pregnancies 
and longtime delay between first pregnancy and 
menarche (2). However, the association between 
menstrual factors and endometriosis remains 
unclear because some studies fail to show a re-
lationship between these factors and the disease 
(27, 38). Nevertheless, other studies found that 
women with endometriosis reported apparently 
either shorter or longer and heavier menstrua-
tion than normal cycle (39, 40). Stovall et al. 
(41) have found menstrual cycle ≤27 days as a 
risk factor that seems to be associated to endo-
metriosis in infertile women. 
The results of the present study showed that 
the stage of endometriosis, according to the 
rASRM classification, is related to the presence 
of pain. We found a significant difference be-
tween stage and symptoms of endometriosis.
Vercellini et al. (42) reported that endometrio-
sis associated symptoms of endometriosis, such 
as dyspareunia, dysmenorrhea and pelvic pain 
and endometriosis stage is directly related to the 
persistence of that symptom. Arruda et al. (43) 
reported disease stage was significantly associ-
ated with severity of dysmenorrhoea and non-
menstrual pain.
 The Italian study (44) showed no relationship 
between the intensity of pain and the stage of the 
disease. In another study, on 469 women aged 18-
45 years old revealed that no clear-cut association 
between stage, site or morphological characteris-
tics of pelvic endometriosis and pain (45). 
In our study, infertile women who experienced 
dysmenorrhea were more likely to have endo-
metriosis rather than women reported no pain 
during their menstruation. Therefore, if more se-
vere dysmenorrhea is associated with increased 
risk of contractility and expulsion menstrual 
debris into the pelvic, severe cramps may sug-
gest susceptibility to the disease (1). Pelvic pain 
is often used as a diagnostic tool for endome-
triosis with dysmenorrhea being the most com-
monly reported symptom (14, 27). Pelvic pain 
might predispose women to endometriosis via 
retrograde menstruation (23). There was also a 
significant difference of increasing risk of endo-
metriosis with the reported pelvic pain, dysmen-
orrheal and dyspareunia (12). In our study, we 
found significant difference between endometri-
osis and pelvic pain occurring during ovulation 
in contrast to what was found by Treloar et al. 
(34). The cul-de-sac and uterosacral ligaments 
are the most common sites of endometriosis 
(46). Dyspareunia may be common complaint 
among women with endometriosis because these 
areas are stretched during intercourse (9).
Use of contraception, as OCs and IUD, are 
also known to affect menstrual flow. If retro-
grade menstruation is involved in the etiology of 
endometriosis, usage of IUD (a common cause 
of menorrhagia) would be expected to increase 
the risk of the disease. Hughes et al. (47) have 
suggested that use of IUD not influence the de-
velopment of endometriosis. In other study, OC 
exposure was associated with a lower risk of en-
dometriosis (48). Our results indicate no signifi-
cant difference between IUD and OCs exposure 
and endometriosis in infertile women. 
In the present study, we observed a positive 
correlation between the previously operated pel-
vic and endometriosis. In addition, family his-
tory of endometriosis was prevalent among the 
patients with the disease compared with patients 
with a normal pelvis (P<0.001). This point was 
also confirmed by the other authors (49-50). 
These data appear to confirm that a familial ten-
dency toward endometriosis, and also suggest 
that genetic risk factor in the pathogenesis of 
endometriosis exist (33).
Interestingly, in our study, the endometriosis 
group commonly reported constipation (61.4 vs. 
38.6%) and diarrhea (96.2 vs. 3.8%), suggesting 
that irritable bowel syndrome be considered as a 
co-morbidity.
Finally, various factors may be useful in 
screening for endometriosis and predict risk of 
an endometriosis diagnosis. Patient characteris-
tics, gravidity, family history of endometriosis, 
history of galactorrhea, history of pelvic sur-
gery, dysmenorrhoea, pelvic pain, dysparaunia, 
premenstrual spotting, fatigue, diarrhea, and the 
number of pregnancies have been evaluated as 
predictors of endometriosis. Thus, infertility 
center should have enough information about 
the symptoms of endometriosis in order to pro-
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vide more information for patients. The find-
ings suggest that gravidity, family history of 
endometriosis, history of galactorrhea, history 
of pelvic surgery, dysmenorrhoea, pelvic pain, 
dysparaunia, premenstrual spotting, fatigue, and 
diarrhea were significantly positively associated 
with endometriosis. However, number of preg-
nancies was negatively related to endometriosis. 
Our models can be used with the almost and 
highest reliability as a guide to screen for en-
dometriosis, in patients comparable to the de-
veloping population. The effects of using these 
models in patient care have to be further investi-
gated. In addition to high prevalence of endome-
triosis, consultation in relation to risk factors for 
endometriosis will be helpful for early detection 
and prevention of disease.
Only a prospective cohort study can specify 
to what extent any of these characteristics indi-
cate risk-factors for different stages of endome-
triosis. Although our results show that there is 
a relationship between pain symptoms, disease 
severity and infertility, it may also help to focus 
the future of epidemiologic studies regarding 
prevention and treatment for the endometriosis.
Conclusion
There is a decreasing risk of endometriosis in 
currently infertile women with history of preg-
nancy and an increased risk in infertile women 
reporting a history of dysmenorrhea, family his-
tory of endometriosis, history of galactorrahea, 
history of pelvic surgery, dysmenorrhoea, pelvic 
pain, dysparunia, premenstrual spotting, fatigue 
and diarrhea. Due to the high prevalence of endo-
metriosis, consultation in relation to risk factors 
for endometriosis, we will be helpful for early 
screening, detection and prevention of disease.  
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